World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 10 April 2023
Main ID:  NCT02240745
Date of registration: 11/09/2014
Prospective Registration: Yes
Primary sponsor: University Hospital Inselspital, Berne
Public title: New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography 3-DSE
Scientific title: New Three-dimensional Methods of Analysis for the Detection of Coronary Artery Disease by Dobutamine Stress Echocardiography
Date of first enrolment: November 30, 2014
Target sample size: 100
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02240745
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Switzerland
Contacts
Name:     Stefano de Marchi, Senior consultant
Address: 
Telephone:
Email:
Affiliation:  Dept. of Cardiology, University Hospital of Bern, Bern
Key inclusion & exclusion criteria

Inclusion Criteria:

- Scheduled elective coronary angiography

- Age >/= 18 years

- Written informed consent

Exclusion Criteria

- Age < 18 years

- Acute coronary syndrome

- Unstable angina pectoris

- Coronary 3-vessel disease

- Left-main artery affected

- Situation after myocardial infarction

- Coronary anomaly

- Situation after coronary bypass

- Congenital heart disease

- Pacemaker

- Any contraindication concerning stress-echo



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Coronary Artery Disease
Echocardiography, Stress
Intervention(s)
Other: Stress-echocardiography
Primary Outcome(s)
Area Strain in the affected coronary artery stenosis myocardial segments (Reference: Coronary flow reserve CFR) [Time Frame: After dobutamin-stress-echocardiography, PTCA will be performed within aprox.1-3hours]
Secondary Outcome(s)
Area at Risk: Surface Area of site with reduced strain relative to the total LV-surface [Time Frame: After dobutamin-stress-echocardiography, PTCA will be performed within aprox.1-3hours]
Secondary ID(s)
039/14
SNCTP 0761
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history